Document Detail

Mesenchymal Stem Cells Induce Resistance to Chemotherapy through the Release of Platinum-Induced Fatty Acids.
MedLine Citation:
PMID:  21907927     Owner:  NLM     Status:  In-Data-Review    
The development of resistance to chemotherapy is a major obstacle for lasting effective treatment of cancer. Here, we demonstrate that endogenous mesenchymal stem cells (MSCs) become activated during treatment with platinum analogs and secrete factors that protect tumor cells against a range of chemotherapeutics. Through a metabolomics approach, we identified two distinct platinum-induced polyunsaturated fatty acids (PIFAs), 12-oxo-5,8,10-heptadecatrienoic acid (KHT) and hexadeca-4,7,10,13-tetraenoic acid (16:4(n-3)), that in minute quantities induce resistance to a broad spectrum of chemotherapeutic agents. Interestingly, blocking central enzymes involved in the production of these PIFAs (cyclooxygenase-1 and thromboxane synthase) prevents MSC-induced resistance. Our findings show that MSCs are potent mediators of resistance to chemotherapy and reveal targets to enhance chemotherapy efficacy in patients.
Jeanine M L Roodhart; Laura G M Daenen; Edwin C A Stigter; Henk-Jan Prins; Johan Gerrits; Julia M Houthuijzen; Marije G Gerritsen; Henk S Schipper; Marieke J G Backer; Miranda van Amersfoort; Joost S P Vermaat; Petra Moerer; Kenji Ishihara; Eric Kalkhoven; Jos H Beijnen; Patrick W B Derksen; Rene H Medema; Anton C Martens; Arjan B Brenkman; Emile E Voest
Related Documents :
3708987 - Incorporation of a new radioactive compound, 4+sn-117m dtpa, into normal and burred rat...
6587397 - Antibodies against gamma-aminobutyric acid: specificity studies and immunocytochemical ...
8082687 - Riluzole, a novel antiglutamate, blocks gaba uptake by striatal synaptosomes.
11358177 - Levels of acc and related compounds in exudate and extracts of canola seeds treated wit...
18367217 - Simultaneous quantification of major phytohormones and related compounds in crude plant...
12005137 - Generation of controlled atmospheres for the determination of the irritant potency of p...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Cancer cell     Volume:  20     ISSN:  1878-3686     ISO Abbreviation:  Cancer Cell     Publication Date:  2011 Sep 
Date Detail:
Created Date:  2011-09-12     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101130617     Medline TA:  Cancer Cell     Country:  United States    
Other Details:
Languages:  eng     Pagination:  370-83     Citation Subset:  IM    
Copyright Information:
Copyright © 2011 Elsevier Inc. All rights reserved.
Department of Medical Oncology (F02.126), University Medical Center Utrecht, P.O. Box 85500, 3508 GA Utrecht, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Rho kinase regulates the survival and transformation of cells bearing oncogenic forms of KIT, FLT3, ...
Next Document:  An integrated in vitro and in vivo high-throughput screen identifies treatment leads for ependymom...